![AML Hub(@AML_Hub) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
AML Hub
@AML_Hub
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm
ID:3289960226
http://www.aml-hub.com 24-07-2015 14:13:43
7,1K Tweets
7,6K Followers
2,2K Following
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
📢 April 21 is #AMLWorldAwarenessDay ! 📢
Let us unite and raise awareness of #AcuteMyeloidLeukemia ! 🌎
Join the collective voice advocating for patients with this cancer.
To learn how to get involved, visit: loom.ly/AkyDt8s
#KnowAML
![AML Hub (@AML_Hub) on Twitter photo 2024-04-19 08:02:16 📢 April 21 is #AMLWorldAwarenessDay! 📢 Let us unite and raise awareness of #AcuteMyeloidLeukemia! 🌎 Join the collective voice advocating for patients with this cancer. To learn how to get involved, visit: loom.ly/AkyDt8s #KnowAML 📢 April 21 is #AMLWorldAwarenessDay! 📢 Let us unite and raise awareness of #AcuteMyeloidLeukemia! 🌎 Join the collective voice advocating for patients with this cancer. To learn how to get involved, visit: loom.ly/AkyDt8s #KnowAML](https://pbs.twimg.com/media/GLg0sTHX0AItQrr.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
CONGRESS | #EBMT24
Christina Rautenberg from Uniklinikum Essen, discusses if CPX-351 is an efficient treatment for patients with high-risk AML using updated real-world data with an extended 3-year follow-up.
The EBMT #TheEBMT #leusm #MedicalCongress
![AML Hub (@AML_Hub) on Twitter photo 2024-04-17 12:48:21 CONGRESS | #EBMT24 Christina Rautenberg from @UniklinikEssen, discusses if CPX-351 is an efficient treatment for patients with high-risk AML using updated real-world data with an extended 3-year follow-up. @TheEBMT #TheEBMT #leusm #MedicalCongress CONGRESS | #EBMT24 Christina Rautenberg from @UniklinikEssen, discusses if CPX-351 is an efficient treatment for patients with high-risk AML using updated real-world data with an extended 3-year follow-up. @TheEBMT #TheEBMT #leusm #MedicalCongress](https://pbs.twimg.com/media/GLXjMTyWcAAaU7u.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
![AML Hub(@AML_Hub) 's Twitter Profile Photo AML Hub(@AML_Hub) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1768208654661042176/NQPc6_Wt_200x200.jpg)
CONGRESS | #EBMT24
Arnon Nagler, Arnon Nagler delivers an interesting presentation on the validation of the ICC 2022 classification in AML patients with myelodysplasia-related changes who are undergoing allo-HSCT from the ALWP of the EBMT.
The EBMT #leusm #MedicalCongress
![AML Hub (@AML_Hub) on Twitter photo 2024-04-17 11:39:31 CONGRESS | #EBMT24 Arnon Nagler, @nagler_EBMT delivers an interesting presentation on the validation of the ICC 2022 classification in AML patients with myelodysplasia-related changes who are undergoing allo-HSCT from the ALWP of the EBMT. @TheEBMT #leusm #MedicalCongress CONGRESS | #EBMT24 Arnon Nagler, @nagler_EBMT delivers an interesting presentation on the validation of the ICC 2022 classification in AML patients with myelodysplasia-related changes who are undergoing allo-HSCT from the ALWP of the EBMT. @TheEBMT #leusm #MedicalCongress](https://pbs.twimg.com/media/GLXTccsWcAAWY0a.jpg)